Search

everythinglearnresearchcommunity

for

Search:↓

The study found that skin conditions in COVID-19 patients can signal serious internal organ damage and may be life-threatening.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Treating cystoid macular oedema in uveitis is difficult and risky.

COVID-19 can cause various skin symptoms, with different patterns seen in younger and older patients.

Reactive lipids from aging cells change the extracellular matrix, affecting cell function and inflammation.

IND-Ca ointment effectively reduces inflammation with minimal skin irritation.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Intralesional steroids effectively treated a young female's scalp nodules without recurrence.

Iron deficiency worsens inflammatory skin diseases by disrupting iron balance and increasing inflammation.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Oxidized LDL reduces cell growth but affects stem cell differentiation less negatively than cytokine-induced inflammation.

The document concludes that corticosteroids effectively treat vasculitis allergica in over 90% of cases, with long-term kidney issues being the main adverse outcome.

Feline cutaneous lymphocytosis is likely reactive, while canine cutaneous lymphocytosis needs more study to understand its nature.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Latanoprost may cause scalp inflammation and delayed healing.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Innate lymphoid cells type 1 may contribute to alopecia areata.

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.

Steroid treatment improved both gut and nerve symptoms in a man with Cronkhite–Canada syndrome.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

Ovalbumin–aluminum sensitization causes increased pain sensitivity and nerve changes in mice.

Higher CRHR1 levels in AA patients lead to increased inflammation.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Necrobiosis lipoidica may need new criteria for accurate diagnosis due to similarities with another condition.

Skin inflammation can worsen intestinal inflammation and colitis.

Ulcerative colitis can cause skin issues due to immune system problems.